SINGAPORE (Apr 27): RHB is maintaining its “neutral” call on TalkMed Group with a lower target price of 70 cents from 72 cents previously after the group reported a weak 1Q18 set of financial results.
To recap, the private healthcare services group saw its topline fall 25.7% on-year due to the eight-month suspension of its key revenue contributor and CEO, Ang Peng Tiam, who only resumed his medical duties last month on Mar 25.
See: TalkMed reports 37.2% fall in 1Q earnings to $5.1 mil
For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
